BioGenomics Ltd.
Sudhir Joshi is an accomplished business development professional with extensive experience in the biosciences sector. Currently serving as Head of Business Development at BioGenomics Ltd. since July 2013, Sudhir focuses on licensing late-stage biosimilar assets in Diabetes, Oncology, and Infectious Diseases, alongside managing global sales of Recombinant AOF enzymes. Previously, at Avesthagen from October 2006 to June 2013, Sudhir successfully licensed early and late-stage biosimilar products in emerging markets, notably securing an exclusive licensing transaction for a mammalian biosimilar. Sudhir's career commenced at Amersham Biosciences as a Product Executive and included a role at MILLIPORE (India) Pvt. Ltd. as Senior Specialist in Application Engineering and Process Development Services, where support was provided to biotech customers across India. Education was completed at Kendriya Vidyalaya.
This person is not in any teams
This person is not in any offices
BioGenomics Ltd.
Biogenomics is a Science driven enterprise. Led by eminent scientists, business professionals and a focussed team of molecular biologists, microbiologists and protein engineers, Biogenomics has, in a short span of 10 years, developed dozens of Biopharmaceuticals and Biotech products. Biogenomics has a strong scientific base and we aim to innovate and adapt to the changing socio-economic demands of healthcare, at every stage, from Laboratory Bench to Manufacturing Shopfloor. Young, rapidly growing biopharmaceutical firm, Biogenomics is on a trajectory of delivering excellence in healthcare. We draw from our core desire of wanting to enrich lives with high-quality and valuable drugs. Our mission is to deliver affordable healthcare and to do all we can to ensure patient access to expensive specialty pharmaceuticals and biological drugs.